Effect of interferon-α therapy on epitope-specific cytotoxic T lymphocyte responses in hepatitis C virus-infected individuals
- 1 January 2002
- journal article
- Published by Wiley in European Journal of Immunology
- Vol. 32 (1) , 144-154
- https://doi.org/10.1002/1521-4141(200201)32:1<144::aid-immu144>3.0.co;2-x
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Detection of Diverse Hepatitis C Virus (HCV)-Specific Cytotoxic T Lymphocytes in Peripheral Blood of Infected Persons by Screening for Responses to All Translated Proteins of HCVJournal of Virology, 2001
- Conserved hepatitis C virus sequences are highly immunogenic for CD4+ T cells: Implications for vaccine developmentHepatology, 1999
- DEGRADATION OF CELL PROTEINS AND THE GENERATION OF MHC CLASS I-PRESENTED PEPTIDESAnnual Review of Immunology, 1999
- The lifespan of major histocompatibility complex class I/peptide complexes determines the efficiency of cytotoxic T‐lymphocyte responsesImmunology, 1999
- Enhanced in vitro potency and in vivo immunogenicity of a CTL epitope from hepatitis C virus core protein following amino acid replacement at secondary HLA-A2.1 binding positions.Journal of Clinical Investigation, 1998
- Contribution of proteasome-mediated proteolysis to the hierarchy of epitopes presented by major histocompatibility complex class I moleculesImmunity, 1995
- Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif.Journal of Clinical Investigation, 1995
- Determinant selection of major histocompatibility complex class I-restricted antigenic peptides is explained by class I-peptide affinity and is strongly influenced by nondominant anchor residues.The Journal of Experimental Medicine, 1994
- Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 moleculesCell, 1993
- Characterization of Peptides Bound to the Class I MHC Molecule HLA-A2.1 by Mass SpectrometryScience, 1992